Ars Pharmaceuticals, Inc. (SPRY) — SC 13D/A Filings
All SC 13D/A filings from Ars Pharmaceuticals, Inc.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (3)
-
Pratik Shah Trust Amends ARS Pharma Stake
— Jun 17, 2024 Risk: medium
The Pratik Shah Living Trust, dated June 15, 2011, has amended its Schedule 13D filing for ARS Pharmaceuticals, Inc. on June 17, 2024. The filing indicates a ch -
Pratik Shah Trust Amends ARS Pharma Stake
— Jun 11, 2024 Risk: medium
The Pratik Shah Living Trust, dated June 15, 2011, has amended its Schedule 13D filing for ARS Pharmaceuticals, Inc. on June 11, 2024. This amendment indicates -
RA Capital Management Amends ARS Pharma Stake
— Mar 29, 2024 Risk: medium
RA Capital Management, L.P. and its affiliates, including Peter Kolchinsky and Ra Rajiv Shah, have amended their Schedule 13D filing for ARS Pharmaceuticals, In
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX